LATE BREAKING ABSTRACT: MOST - My Own Specific Therapy - A multicenter, randomized, open-label, phase II trial evaluating the clinical benefit of a...

Date 27 September 2015
Event European Cancer Congress 2015
Session Early Drug Development II
Topics Drug Development
Presenter Blay, J.Y.